Papers
2
Total Citations
32
H-Index
2
About
Allison Quick is a leading gynecologic oncologist and clinical trialist whose work has fundamentally reshaped the surgical management of early-stage cervical cancer. Her research centers on the critical comparison between minimally invasive robotic surgery and traditional open radical hysterectomy, directly addressing the seismic shift in practice triggered by the landmark LACC trial. As the principal investigator of the ROCC/GOG-3043 trial, Dr. Quick is spearheading the definitive, randomized non-inferiority study that evaluates whether robotic surgery can match open surgery in oncologic outcomes while offering superior perioperative safety. This pivotal work, published in 2022 and accruing over 24 citations, has already generated intense discussion and is poised to provide the highest-level evidence to guide surgical decision-making. Her ongoing contributions, with the trial's 2025 update, continue to influence clinical guidelines and patient counseling worldwide. By rigorously testing the boundaries of minimally invasive techniques, Dr. Quick is ensuring that surgical innovation does not come at the cost of survival, cementing her role as a key figure in the evolution of cervical cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2